Logo image of XELB

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

NASDAQ:XELB - Nasdaq - US98400M1018 - Common Stock - Currency: USD

2.63  -0.37 (-12.33%)

Fundamental Rating

1

XELB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. XELB may be in some trouble as it scores bad on both profitability and health. XELB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XELB had negative earnings in the past year.
In the past year XELB has reported a negative cash flow from operations.
XELB had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: XELB reported negative operating cash flow in multiple years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

XELB's Return On Assets of -40.94% is on the low side compared to the rest of the industry. XELB is outperformed by 90.08% of its industry peers.
With a Return On Equity value of -59.89%, XELB is not doing good in the industry: 73.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -40.94%
ROE -59.89%
ROIC N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

XELB has a Gross Margin of 93.09%. This is amongst the best in the industry. XELB outperforms 99.17% of its industry peers.
XELB's Gross Margin has declined in the last couple of years.
XELB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XELB has more shares outstanding
The number of shares outstanding for XELB has been increased compared to 5 years ago.
XELB has a worse debt/assets ratio than last year.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

XELB has an Altman-Z score of -2.20. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XELB (-2.20) is worse than 83.47% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that XELB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, XELB is in the better half of the industry, outperforming 70.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -2.2
ROIC/WACCN/A
WACC8.37%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.52 indicates that XELB may have some problems paying its short term obligations.
The Current ratio of XELB (0.52) is worse than 93.39% of its industry peers.
A Quick Ratio of 0.52 indicates that XELB may have some problems paying its short term obligations.
The Quick ratio of XELB (0.52) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for XELB have decreased strongly by -39.19% in the last year.
Looking at the last year, XELB shows a very negative growth in Revenue. The Revenue has decreased by -52.22% in the last year.
XELB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.93% yearly.
EPS 1Y (TTM)-39.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-52.22%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-27.49%

3.2 Future

Based on estimates for the next years, XELB will show a very strong growth in Earnings Per Share. The EPS will grow by 47.92% on average per year.
Based on estimates for the next years, XELB will show a small growth in Revenue. The Revenue will grow by 1.94% on average per year.
EPS Next Y-286.36%
EPS Next 2Y7.24%
EPS Next 3Y47.92%
EPS Next 5YN/A
Revenue Next Year-50.07%
Revenue Next 2Y-7.37%
Revenue Next 3Y1.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XELB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

XELB's earnings are expected to grow with 47.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.24%
EPS Next 3Y47.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XELB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCEL BRANDS INC

NASDAQ:XELB (4/25/2025, 2:45:40 PM)

2.63

-0.37 (-12.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)05-19 2025-05-19/amc
Inst Owners25.19%
Inst Owner Change-0.32%
Ins Owners38.6%
Ins Owner Change3.19%
Market Cap6.23M
Analysts82.86
Price Target19.13 (627.38%)
Short Float %N/A
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.25%
Min EPS beat(2)54.75%
Max EPS beat(2)87.75%
EPS beat(4)4
Avg EPS beat(4)49.84%
Min EPS beat(4)5.88%
Max EPS beat(4)87.75%
EPS beat(8)6
Avg EPS beat(8)26.78%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-11.64%
Max Revenue beat(2)7.72%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-11.64%
Max Revenue beat(4)7.72%
Revenue beat(8)3
Avg Revenue beat(8)1.49%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)900%
PT rev (3m)837.5%
EPS NQ rev (1m)-1087.5%
EPS NQ rev (3m)-1800%
EPS NY rev (1m)-986.96%
EPS NY rev (3m)-861.54%
Revenue NQ rev (1m)-13.53%
Revenue NQ rev (3m)-32.18%
Revenue NY rev (1m)-3.22%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 4.88
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)-2.97
OCFYN/A
SpS3.94
BVpS15.58
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.94%
ROE -59.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.09%
FCFM N/A
ROA(3y)-14.53%
ROA(5y)-11.3%
ROE(3y)-21.38%
ROE(5y)-16.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.17%
GM growth 5Y-7.95%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.13%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -2.2
F-Score2
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)7.23%
Cap/Depr(5y)58.14%
Cap/Sales(3y)1.53%
Cap/Sales(5y)6.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-286.36%
EPS Next 2Y7.24%
EPS Next 3Y47.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-52.22%
Revenue growth 3Y-15.52%
Revenue growth 5Y-12.93%
Sales Q2Q%-27.49%
Revenue Next Year-50.07%
Revenue Next 2Y-7.37%
Revenue Next 3Y1.94%
Revenue Next 5YN/A
EBIT growth 1Y44.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.29%
EBIT Next 3Y35.99%
EBIT Next 5YN/A
FCF growth 1Y41.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.61%
OCF growth 3YN/A
OCF growth 5YN/A